Outcomes assessed at T0 (baseline) and T1 (3 months after) | Â | ||
---|---|---|---|
 | T0 Median Interquartile range in [] | T1 Median Interquartile range in [] | Missing cases |
Von Korff pain graduation (0 (no pain)- 4 (high pain-related impairment) | Intervention:3 [3–4] | Intervention: 2 [1–3] | 5 |
Control: 3.5 [3–4] | Control: 2 [1–3] | 1 | |
Von Korff pain intensity (0 (no pain)– 100 (highest imaginable pain) | Intervention: 57 [43-65.5] | Intervention: 56.66 [41.5–64] | 3 |
Control: 66 [54.25–75.75] | Control: 59.8 [47.25–69.75] | 1 | |
SF-12 PCS (0 (lower)– 100 (higher physical related quality of life)) | Intervention: 40 [37–43] | Intervention: 33.72 [33.23–40.24] | 6 |
Control: 30 [28–36] | Control: 33.6 [27.1–40.7] | 5 | |
SF-12 MCS (0 (lower)– 100 (higher mental health related quality of life)) | Intervention: 39.5 [36-42.75] | Intervention: 48.81 [35.8-55.18] | 6 |
Control: 45 [34-55.5] | Control: 39.61 [33.92–54.31] |  | |
IPAQ total MET (metabolic equivalent) minutes | Intervention: 7937 [2445–14239] | Intervention: 7572 [5412–10986] | 9 |
Control: 1413 (689–2278] | Control: 14,125 [953–1619] | 7 | |
HADS-A 0 (lower anxiety)- 21 (stronger anxiety) | Intervention: 5 [5-10.75] | Intervention: 8 [4.5–11] | 4 |
Control: 9 [6.75-11] | Control: 9 [5-10.25] | 1 | |
HADS-D 0 (lower depression)-21 (stronger depression) | Intervention: 7 [6–8] | Intervention: 6 [5-9.5] | 3 |
Control: 6 [4-8.25] | Control: 7 [4-8.25] | 1 |